These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27717241)

  • 1. Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy.
    Han B; Copeland CA; Kawano Y; Rosenzweig EB; Austin ED; Shahmirzadi L; Tang S; Raghunathan K; Chung WK; Kenworthy AK
    Traffic; 2016 Dec; 17(12):1297-1312. PubMed ID: 27717241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia.
    Karhan AN; Zammouri J; Auclair M; Capel E; Apaydin FD; Ates F; Verpont MC; Magré J; Fève B; Lascols O; Usta Y; Jéru I; Vigouroux C
    Eur J Endocrinol; 2021 Nov; 185(6):841-854. PubMed ID: 34643546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal.
    Copeland CA; Han B; Tiwari A; Austin ED; Loyd JE; West JD; Kenworthy AK
    Mol Biol Cell; 2017 Nov; 28(22):3095-3111. PubMed ID: 28904206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Frame-Shift Mutation in CAV1 Is Associated with a Severe Neonatal Progeroid and Lipodystrophy Syndrome.
    Schrauwen I; Szelinger S; Siniard AL; Kurdoglu A; Corneveaux JJ; Malenica I; Richholt R; Van Camp G; De Both M; Swaminathan S; Turk M; Ramsey K; Craig DW; Narayanan V; Huentelman MJ
    PLoS One; 2015; 10(7):e0131797. PubMed ID: 26176221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
    Tomita S; Nakanishi N; Ogata T; Higuchi Y; Sakamoto A; Tsuji Y; Suga T; Matoba S
    Commun Biol; 2024 Jan; 7(1):40. PubMed ID: 38182755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome.
    Garg A; Kircher M; Del Campo M; Amato RS; Agarwal AK;
    Am J Med Genet A; 2015 Aug; 167A(8):1796-806. PubMed ID: 25898808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant caveolin-1-mediated Smad signaling and proliferation identified by analysis of adenine 474 deletion mutation (c.474delA) in patient fibroblasts: a new perspective on the mechanism of pulmonary hypertension.
    Marsboom G; Chen Z; Yuan Y; Zhang Y; Tiruppathi C; Loyd JE; Austin ED; Machado RF; Minshall RD; Rehman J; Malik AB
    Mol Biol Cell; 2017 May; 28(9):1177-1185. PubMed ID: 28468941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maladaptative Autophagy Impairs Adipose Function in Congenital Generalized Lipodystrophy due to Cavin-1 Deficiency.
    Salle-Teyssières L; Auclair M; Terro F; Nemani M; Elsayed SM; Elsobky E; Lathrop M; Délépine M; Lascols O; Capeau J; Magré J; Vigouroux C
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2892-904. PubMed ID: 27144934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
    Rajab A; Straub V; McCann LJ; Seelow D; Varon R; Barresi R; Schulze A; Lucke B; Lützkendorf S; Karbasiyan M; Bachmann S; Spuler S; Schuelke M
    PLoS Genet; 2010 Mar; 6(3):e1000874. PubMed ID: 20300641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.
    Kim CA; Delépine M; Boutet E; El Mourabit H; Le Lay S; Meier M; Nemani M; Bridel E; Leite CC; Bertola DR; Semple RK; O'Rahilly S; Dugail I; Capeau J; Lathrop M; Magré J
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1129-34. PubMed ID: 18211975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension.
    Austin ED; Ma L; LeDuc C; Berman Rosenzweig E; Borczuk A; Phillips JA; Palomero T; Sumazin P; Kim HR; Talati MH; West J; Loyd JE; Chung WK
    Circ Cardiovasc Genet; 2012 Jun; 5(3):336-43. PubMed ID: 22474227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of the P132L disease mutation in caveolin-1 reveals its role in the assembly of oligomeric complexes.
    Han B; Gulsevin A; Connolly S; Wang T; Meyer B; Porta J; Tiwari A; Deng A; Chang L; Peskova Y; Mchaourab HS; Karakas E; Ohi MD; Meiler J; Kenworthy AK
    J Biol Chem; 2023 Apr; 299(4):104574. PubMed ID: 36870682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cavin-1/PTRF leucine zipper domain 2 and its congenital generalized lipodystrophy mutant with model membranes.
    Mohapatra A; Lokappa SB; Chaudhary N
    Biochem Biophys Res Commun; 2020 Jan; 521(3):732-738. PubMed ID: 31706570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential impact of caveolae and caveolin-1 scaffolds on the membrane raft proteome.
    Zheng YZ; Boscher C; Inder KL; Fairbank M; Loo D; Hill MM; Nabi IR; Foster LJ
    Mol Cell Proteomics; 2011 Oct; 10(10):M110.007146. PubMed ID: 21753190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.
    Dwianingsih EK; Takeshima Y; Itoh K; Yamauchi Y; Awano H; Malueka RG; Nishida A; Ota M; Yagi M; Matsuo M
    Mol Genet Metab; 2010; 101(2-3):233-7. PubMed ID: 20638880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties.
    Le Saux O; Teeters K; Miyasato S; Choi J; Nakamatsu G; Richardson JA; Starcher B; Davis EC; Tam EK; Jourdan-Le Saux C
    Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L1007-17. PubMed ID: 18849439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolar dysfunction and lipodystrophies.
    Patni N; Hegele RA; Garg A
    Eur J Endocrinol; 2022 Jan; 186(3):C1-C4. PubMed ID: 34935636
    [No Abstract]   [Full Text] [Related]  

  • 18. Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.
    Gairhe S; Awad KS; Dougherty EJ; Ferreyra GA; Wang S; Yu ZX; Takeda K; Demirkale CY; Torabi-Parizi P; Austin ED; Elinoff JM; Danner RL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly and Turnover of Caveolae: What Do We Really Know?
    Han B; Copeland CA; Tiwari A; Kenworthy AK
    Front Cell Dev Biol; 2016; 4():68. PubMed ID: 27446919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
    Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
    Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.